Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5913-5924
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5913
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5913
Table 3 Association between thymidylate synthase polymorphisms and patient characteristics
| Polymorphism | Characteristic | RR (95%CI) | P value |
| 2R | Age < 65-years-old | 1.708 (1.158-2.520) | 0.090 |
| 2RG/3RG | Grade 1-2 | 1.449 (1.077-1.948) | 0.044 |
| 2RG/3RC | Female | 1.943 (1.152-3.275) | 0.036 |
| ins/ins | KRAS G12D | 3.563 (1.163-10.912) | 0.045 |
| 3RG/3RC | KRAS wild-type | 1.753 (1.156-2.657) | 0.031 |
- Citation: Ntavatzikos A, Spathis A, Patapis P, Machairas N, Peros G, Konstantoudakis S, Leventakou D, Panayiotides IG, Karakitsos P, Koumarianou A. Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World J Gastroenterol 2017; 23(32): 5913-5924
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5913.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5913